High-flow Nasal Oxygenation for Open Mouth

Sponsor
Seoul National University Hospital (Other)
Overall Status
Terminated
CT.gov ID
NCT04290728
Collaborator
(none)
15
1
2
10.2
1.5

Study Details

Study Description

Brief Summary

This study aims to evaluate the effect of high-flow nasal oxygenation on safe apnea time for children undergoing general anesthesia, with their mouth open.

Condition or Disease Intervention/Treatment Phase
  • Device: Apnea with high-flow nasal cannula
  • Other: Apnea
N/A

Detailed Description

Oxygenation via high-flow nasal cannula is gaining popularity in various clinical settings. It is known to increase apnea time for apneic patients including children. However, high-flow nasal cannula is known to be ineffective when the patient's mouth is kept open.

When trying to intubate the patient during induction of anesthesia, the patient should be apneic with administration of neuromuscular blocking agent, and the mouth should be open for introduction of laryngoscope.

We designed a prospective randomized controlled study to evaluate the effect of high-flow nasal oxygenation in the aforementioned setting for trying to intubate the patient.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized, controlled clinical trialRandomized, controlled clinical trial
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effect of High-flow Nasal Oxygenation on Safe Apnea Time in Children With Open Mouth
Actual Study Start Date :
Apr 16, 2020
Actual Primary Completion Date :
Feb 19, 2021
Actual Study Completion Date :
Feb 19, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: High flow

Apply high-flow nasal oxygenation during apnea with open mouth after adequate preoxygenation. Resume bag-mask ventilation when pulse oximetry drops to 92% or pre-set apnea time has expired.

Device: Apnea with high-flow nasal cannula
Application of oxygenation with high-flow nasal cannula with a rate of 2L/kg/min
Other Names:
  • Airvo 2
  • Active Comparator: Control

    Apply nothing during apnea with open mouth after adequate preoxygenation. Resume bag-mask ventilation when pulse oximetry drops to 92% or pre-set apnea time has expired.

    Other: Apnea
    Apnea without any application of oxygenation

    Outcome Measures

    Primary Outcome Measures

    1. Apnea time [Elapsed time starting from discontinuation of oxygen to the time point that pulse oximetry first reaches 92% (not to exceed 520 seconds)]

      Time required for pulse oximetry to drop to 92% after start of apnea

    Secondary Outcome Measures

    1. End-tidal carbon dioxide [Procedure (From induction of anesthesia to end of anesthesia)]

      End-tidal carbon dioxide partial pressure during anesthesia

    2. Pulse oximetry [Procedure (From induction of anesthesia to end of anesthesia)]

      Pulse oximetry during anesthesia

    3. Non-invasive blood pressure [Procedure (From induction of anesthesia to end of anesthesia)]

      Non-invasive blood pressure measured from forearm or leg

    4. Oxygen reserve index [Procedure (From induction of anesthesia to end of anesthesia)]

      Oxygen reserve index measured from finger or toe

    5. Time to 100% [Elapsed time starting from re-start of bag-mask ventilation at the end of apnea period to the time point that pulse oximetry first reaches 100% (estimated less than 2 minutes)]

      Elapsed time from re-start of bag-mask ventilation to recovery of pulse oximetry of 100% after apnea

    6. Minimum value of pulse oximetry [Procedure (From induction of anesthesia to end of anesthesia)]

      Minimum value of pulse oximetry after re-start of bag-mask ventilation after apnea

    7. 1st value of end-tidal carbon dioxide [At expiration of the first manual ventilation after the end of the apnea period (less than 520 seconds after start of apnea period)]

      First measured value of end-tidal carbon dioxide partial pressure after re-start of bag-mask ventilation after apnea

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 10 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Children younger than 11 years old scheduled to undergo surgery under general anesthesia, with American Society of Anesthesiologists Physical Status 1 or 2.
    Exclusion Criteria:
    • Refusal to enrollment from one or more of legal guardians of the patient

    • Children who are planned to use supraglottic airway device

    • Children with upper respiratory tract infection or pulmonary interstitial disease

    • Preterm babies under 40 weeks of postconceptual age

    • Children who are expected to have difficult airway for bag-mask ventilation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Seoul National University Hospital Seoul Korea, Republic of 110-744

    Sponsors and Collaborators

    • Seoul National University Hospital

    Investigators

    • Principal Investigator: Jin-Tae Kim, M.D., Ph.D., Seoul National University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Jin-Tae Kim, Professor, Seoul National University Hospital
    ClinicalTrials.gov Identifier:
    NCT04290728
    Other Study ID Numbers:
    • 1910-091-1071
    First Posted:
    Mar 2, 2020
    Last Update Posted:
    Apr 1, 2021
    Last Verified:
    Mar 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Jin-Tae Kim, Professor, Seoul National University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 1, 2021